Breaking News: New CMS Model Dramatically Reduces Insulin Related Out-of-Pocket Costs for 3 Million Medicare Beneficiaries

Insulin Injectibles

The Centers for Medicare and Medicaid Services blazed serious trails today with the announcement of Part D Senior Savings. The new model may dramatically reduce the out-of-pocket cost of insulin for over 3 million of its Medicare beneficiaries. 

Part D Senior Savings provides Medicare patients with new Part D plan choices offering a thirty-day supply of a variety of plan-formulary insulins for less than $35.